OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
32 hedge funds and large institutions have $19.4M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 4 closing their positions.
Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.55%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
3
Increased
10
Reduced
8
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Two Sigma Advisers
New York
|
$252K |
| 2 |
2
Renaissance Technologies
New York
|
$1.9M |
| 3 |
3
Two Sigma Investments
New York
|
$234K |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$1.21M |
| 5 |
5
D.E. Shaw & Co
New York
|
$0 |
